Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:45:26 EDT Sat 22 Mar 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:IGX - INTELGENX TECHNOLOGIES CORP. J - http://www.intelgenx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
IGX - T  H0.158.50.24    0.285  0.135May 16Jul 1915 min RT 2¢
TSX - TH0.158.50.24    0.285  0.135May 1615 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-07-19 16:05C:IGX0.24News ReleaseIntelGenx Provides Update on Previously Announced Sale and Investment Solicitation Process
2024-07-03 08:00C:IGX0.24News ReleaseIntelGenx Obtains Preliminary Efficacy Results for the 'BUENA' Montelukast VersaFilm(TM) Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer's Disease
2024-06-11 12:45C:IGX0.24News ReleaseIntelGenx receives CCAA protection order, begins SISP
2024-05-28 16:19C:IGX0.24Shares Delisted from TSXIntelGenx Technologies to be delisted from TSX June 27
2024-05-28 14:15C:IGX0.24News ReleaseIntelGenx receives court approval to seek company sale
2024-05-17 19:58C:IGX0.24MiscellaneousIntelGenx Technologies under TSX delisting review
2024-05-17 17:47C:IGX0.24News ReleaseIntelGenx receives order granting CCAA protection
2024-05-17 10:22C:IGX0.24News ReleaseIntelGenx Technologies to apply for creditor protection
2024-05-17 09:01C:IGX0.24Halt TradingIntelGenx Technologies halted at the open
2024-05-16 14:27C:IGX0.205SEDAR Interim MD & ASEDAR Interim MD & A
2024-05-15 16:32C:IGX0.205SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-08 13:00C:IGX0.20News ReleaseIntelGenx shareholders approve all matters at AGM
2024-04-08 12:15C:IGX0.24News ReleaseIntelGenx doses 1st PD patients in Montelukast trial
2024-04-05 10:18C:IGX0.26News ReleaseIntelGenx partner Chemo receives FDA response letter